147 related articles for article (PubMed ID: 38346749)
1. The effect of soy isoflavones in brain development: the emerging role of multiple signaling pathways and future perspectives.
Ariyani W; Koibuchi N
Endocr J; 2024 Apr; 71(4):317-333. PubMed ID: 38346749
[TBL] [Abstract][Full Text] [Related]
2. Soy Isoflavones Accelerate Glial Cell Migration
Ariyani W; Miyazaki W; Amano I; Hanamura K; Shirao T; Koibuchi N
Front Endocrinol (Lausanne); 2020; 11():554941. PubMed ID: 33250856
[TBL] [Abstract][Full Text] [Related]
3. Isoflavones Mediate Dendritogenesis Mainly through Estrogen Receptor α.
Ariyani W; Amano I; Koibuchi N
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240356
[TBL] [Abstract][Full Text] [Related]
4. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Mahmoud AM; Yang W; Bosland MC
J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review.
Ricketts ML; Moore DD; Banz WJ; Mezei O; Shay NF
J Nutr Biochem; 2005 Jun; 16(6):321-30. PubMed ID: 15936643
[TBL] [Abstract][Full Text] [Related]
6. Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia.
Sekikawa A; Wharton W; Butts B; Veliky CV; Garfein J; Li J; Goon S; Fort A; Li M; Hughes TM
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233223
[TBL] [Abstract][Full Text] [Related]
7. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
8. Soy Isoflavones Inhibit Both GPIb-IX Signaling and αIIbβ3 Outside-In Signaling via 14-3-3ζ in Platelet.
Liu M; Wang G; Xu R; Shen C; Ni H; Lai R
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443497
[TBL] [Abstract][Full Text] [Related]
9. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
Rajan RK; M SS; Balaji B
Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones and cognitive function.
Lee YB; Lee HJ; Sohn HS
J Nutr Biochem; 2005 Nov; 16(11):641-9. PubMed ID: 16169201
[TBL] [Abstract][Full Text] [Related]
12. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro.
Casanova M; You L; Gaido KW; Archibeque-Engle S; Janszen DB; Heck HA
Toxicol Sci; 1999 Oct; 51(2):236-44. PubMed ID: 10543025
[TBL] [Abstract][Full Text] [Related]
13. The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.
Van der Eecken H; Joniau S; Berghen C; Rans K; De Meerleer G
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068715
[TBL] [Abstract][Full Text] [Related]
14. [Soy isoflavones--a therapy for menopausal symptoms?].
Wolters M; Hahn A
Wien Med Wochenschr; 2004 Jul; 154(13-14):334-41. PubMed ID: 15368955
[TBL] [Abstract][Full Text] [Related]
15. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
16. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure.
Adams SM; Aksenova MV; Aksenov MY; Mactutus CF; Booze RM
PLoS One; 2012; 7(5):e37540. PubMed ID: 22629415
[TBL] [Abstract][Full Text] [Related]
17. Effects of soy consumption on gonadotropin secretion and acute pituitary responses to gonadotropin-releasing hormone in women.
Nicholls J; Lasley BL; Nakajima ST; Setchell KD; Schneeman BO
J Nutr; 2002 Apr; 132(4):708-14. PubMed ID: 11925465
[TBL] [Abstract][Full Text] [Related]
18. Isoflavone consumption reduces inflammation through modulation of phenylalanine and lipid metabolism.
Shrode RL; Cady N; Jensen SN; Borcherding N; Mangalam AK
Metabolomics; 2022 Oct; 18(11):84. PubMed ID: 36289122
[TBL] [Abstract][Full Text] [Related]
19. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
[TBL] [Abstract][Full Text] [Related]
20. NTP-CERHR expert panel report on the developmental toxicity of soy infant formula.
McCarver G; Bhatia J; Chambers C; Clarke R; Etzel R; Foster W; Hoyer P; Leeder JS; Peters JM; Rissman E; Rybak M; Sherman C; Toppari J; Turner K
Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):421-68. PubMed ID: 21948615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]